+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Tracheobronchial Stent Market Size, Share, & COVID-19 Impact Analysis 2023-2029 - MedCore - Includes: Metal Tracheobronchial Stents, and 1 more

  • PDF Icon


  • 12 Pages
  • February 2023
  • Region: Global
  • iData Research
  • ID: 5744460
The global market for tracheobronchial stents was valued at $216.3 million in 2022, with an anticipated decrease over the forecast period at a CAGR of -2.2%, ultimately reaching $185.7 million. The market report covers both metal and silicone tracheobronchial stents.


  • Unit Sales, Average Selling Prices, Market Size & Growth Trends
  • Procedure Numbers
  • COVID-19 Impact Analysis
  • Market Drivers & Limiters
  • Market Forecasts Until 2029, and Historical Data to 2019
  • Recent Mergers & Acquisitions
  • Company Profiles and Product Portfolios
  • Leading Competitors


A significant factor driving the market growth is the preference for silicone stents over their metal counterparts. Unlike metal stents, which are permanently implanted in a patient's airways, silicone stents can be removed or replaced to mitigate potential complications for the patient.


The Global tracheobronchial market was led by Getinge, Boston Scientific, and Merit Medical.

Getinge was the top player in the tracheobronchial stent industry, operating exclusively in the metal tracheobronchial stent category with its iCAST™ Balloon Expandable Covered Stent. However, it's worth mentioning that a significant portion of the product sales may be utilized off-label for peripheral vascular interventions such as iliac, for which the international variant of the stent, Advanta™ V12, has CE and regional clearance.


Tracheobronchial Stent Market - MedCore - Includes:
  • Metal and silicone tracheobronchial stents.


  • Regions: North America (Canada, United States), Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela), Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.), Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine), Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates), Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam), Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda)
  • Base Year: 2022
  • Forecast Period: 2023-2029
  • Historical Data: 2019-2022
  • Quantitative Data: Market Size, Market Share, Market Growth Rates, Units Sold, Average Selling Prices
  • Qualitative Data: COVID-19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios
  • Data Sources: Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data.

Table of Contents

Tracheobronchial Stent Market
  • Introduction
  • Market Overview
  • Market Analysis and Forecast
  • Tracheobronchial Stent Market
  • Metal Tracheobronchial Stent Market
  • Silicone Tracheobronchial Stent Market
  • Drivers and Limiters
  • Market Drivers
  • Market Limiters
  • Competitive Market Share Analysis

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Getinge
  • Boston Scientific
  • Merit Medical
  • Thoracent
  • Boston Medical
  • Cook Medical
  • LYMOL Medical
  • Hood Laboratories
  • Aohua
  • Asept InMed
  • Atrium
  • Ella-CS
  • Endo-Flex
  • Luda Medica
  • Micro-Tech Co.
  • M.I. Tech
  • Natec Medical
  • Stening